PRESS RELEASE FROM NATURE CLINICAL PRACTICE
This press release is copyrighted to Nature Clinical Practice Cardiovascular Medicine.
Warning: This document, and the Nature Clinical Practice paper to which it refers, may contain information that is price sensitive (as legally defined, for example, in the UK Criminal Justice Act 1993 Part V) with respect to publicly quoted companies. Anyone dealing in securities using information contained in this document or in advanced copies of Nature’s content may be guilty of insider trading under the US Securities Exchange Act of 1934.
PLEASE CITE NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO THE JOURNAL'S SITE: <http://www.nature.com/ncpcardio>
Heart disease a ‘male-only’ condition is a myth
Heart disease should top the list of women’s health concerns but, according to a Viewpoint article to be published in the October issue of Nature Clinical Practice Cardiovascular Medicine, it doesn’t even come close. To raise awareness of this critical issue, Sharonne Hayes explores what we can do to improve the identification and care of women with and at risk of heart disease.
Today, more than six million women in the US live with coronary heart disease, and, since 1984, cardiovascular disease has killed more women than men every year. Yet women still do not receive the same standard of treatment as men and there is a lack of relevant research in women, resulting in a substantial sex-based knowledge gap. Doctors still underestimate women’s cardiovascular risk; women with heart disease receive less-intensive therapy and are more likely to be misdiagnosed than men. This inequality, along with societal misconceptions and a possible biological difference, means that more women with heart disease die than men.
Many women have a disproportionately greater fear of dying from breast cancer than heart disease: a misunderstanding that needs to change. Improving doctors’ awareness of early cardiovascular risk factors and treatment in women, carrying out research and, importantly, making sure women are aware of heart disease, are crucial if we are to improve women’s cardiovascular health.
Sharonne N Hayes (Women's Heart Clinic, Mayo Clinic, Rochester, MN, USA)
Email: [email protected]
Hannah Camm (Editor, Nature Clinical Practice Cardiovascular Medicine)
Tel: +44 020 7843 4836; Email: [email protected]
The Nature Clinical Practice journals
The first four journals launched in November 2004 and a further four in November 2005. This is NPG's most extensive launch programme and the Nature Clinical Practice series is due to extend to 15 titles over the next few years.
Each month the journals filter original research in their field, highlighting the most important research articles, then explaining how the research affects patients' treatments. Content also includes editorial and opinion pieces, highlights from the current literature, commentaries on the application of recent research to practical patient care, thorough reviews, and in-depth case studies.
For North America and Canada
Katie McGoldrick, Nature Washington
Tel: +1 202 737 2355; E-mail: [email protected]
For Japan, Korea, China, Singapore and Taiwan
Itsumi Kitahara, Nature Tokyo
Tel: +81 3 3267 8751; E-mail: [email protected]
For the UK/Europe/other countries not listed above
Ruth Francis, Nature London
Tel: +44 20 7843 4562; E-mail [email protected]
About Nature Publishing Group
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, is the world's most highly-cited weekly multidisciplinary journal and was first published in 1869. Other publications and services include Nature research journals, Nature Reviews, Nature Clinical Practice, a range of prestigious academic journals, including society-owned publications, news content from [email protected] and scientific career information from Naturejobs.
NPG is a global company, with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Gurgaon, Mexico City and Basingstoke. For more information, please go to www.nature.com <http://www.nature.com>.